Skip to content
Monday, March 1, 2021
COA Pharmacy

COA Pharmacy

Community Oncology Pharmacy Association

  • About
    • Mission & Purpose
    • COPA Advisory Board
  • Partners
    • Supporting COPA
    • Athenex
    • BeiGene
    • Cardinal Health
    • Incyte
    • ION Solutions
    • Janssen Oncology
    • MorphoSys
    • Oncopeptides
    • Advertising Information
  • Resources
    • Patient PBM Experiences
    • Latest News
    • Payers
      • Part B / DMERC
      • Part D
    • State Laws
      • CSRO Legislative Map Tool
        • Step Therapy
        • Non-Medical Switching
        • Accumulator Adjustment Program
        • Uniform Prior Authorization
      • J & J Interactive State Tool
        • Medicaid Expansion
        • State Pharmaceutical Assistance Programs (SAPs)
        • Low-Income Subsidy (LIS) Eligibility Information
        • State Health Insurance Assistance Programs (SHIPs)
        • Standard Prior Authorization (PA) Forms
        • National Foundations & Other Nonprofit Resources
        • Oral Parity Laws
        • Advocacy Connector
        • Biosimilar Legislation
        • Continuity of Care
        • State Legislature Resources
      • Step Therapy Legislation By State
      • Pharmacy Dispensing Regulations
    • USP 797/800
    • Patients
  • Membership
    • About Membership
    • Become a Member
    • Member Log In
  • ACHC Accreditation
  • COAnalyzer.Net
  • Studies & Publications
  • Log In >>

USP 797 & 800

USP 797 & 800

As a resource, the Community Oncology Pharmacy Association is providing access to USP 797, Pharmaceutical Compounding-Sterile Preparations and USP 800, Hazardous Drugs-Handling in Healthcare Settings documents. To access these documents, click on the images below.

U.S. Pharmacopeia Chapters <797> and <800> – 2019 Update

  • JNJ USP Pharmacopeia Fact Sheet 

CAN/COPA USP 797 & 800 Call – 2/29/2019

  • United States Pharmacopoeia (USP)
  • National Institute of Occupational Safety and Health (NIOSH)
  • National Association of Boards of Pharmacy (NABP)
  • Pharmacy Purchasing & Products Magazine
  • Accreditation Commission for Health Care (ACHC)
  • Joint Commission Resources – Self Assessment (registration required)
  • Ready for 800 – Sponsored by B Braun
  • Critical Point – Training and Resources (registration required) 

USP Presentations 

  • McKesson USP Presentation
  • ION USP Presentation
  • Cardinal USP Presentation

USP_logo

VIEW USP 797

USP 797
Pharmaceutical Compounding
Sterile Preparations


VIEW USP 800

USP 800
Hazardous Drugs Handling
in Healthcare Settings

 

USP has released new regulations for USP 800 as of 2.1.2016. Click HERE for more information.

News

Latest News 

Pfizer Lawsuit Tests Crackdown on Drugmakers Picking Up Copays

February 26, 2021 copaadmin

A Pfizer Inc. challenge to an enforcement push against drug company and charity collaborations is testing the bounds of the

Latest News 

Is FDA Getting It Right on Cancer Drug Approvals?

February 26, 2021 copaadmin

Archived News

Archived News 

Why CVS Is Giving Plans A New Tool To Target High Launch Prices

September 17, 2018 copaadmin

Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows

Archived News 

Trump administration moves to give Medicare drug plans more control over their offerings

August 30, 2018 copaadmin

Login Status

Forgot?  Register
                                     
                                     
The Community Oncology Pharmacy Association (COPA) was formed in response to the increasing number of community cancer clinics dispensing oral cancer drugs and ancillary therapies. COPA is a non-profit entity, under the direction of COA, that has established national quality standards in partnership with ACHC and will be providing information, education, and resources, enhancing information exchange, and helping advocate for the patient-centric model of integrated, high quality cancer care.

 

© Copyright Community Oncology Alliance | All Rights Reserved | Terms and Conditions | Privacy Policy

For more information, please contact:

Ricky Newton, CPA
Chief Financial & Operating Officer
P: 757-639-4855
E: [email protected]

760 Lynnhaven Parkway
Suite 150
Virginia Beach, VA 23452